Novel function of TWEAK in inducing intervertebral disc degeneration

Journal of Orthopaedic Research

Volumn 25, Issue 11, 2007, Pages 1438-1446

  Wako, Masanori ^a   Haro, Hirotaka ^a   Ando, Takashi ^a   Hatsushika, Kyosuke ^a   Ohba, Tetsuro ^a   Iwabuchi, Sadahiro ^b   Nakao, Atsuhito ^a   Hamada, Yoshiki ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

^b TEIJIN PHARMA LIMITED   (Japan)

Author keywords

Fn14; Intervertebral disc degeneration; MMP 3; Proteoglycan degradation; TWEAK

Indexed keywords

NEUTRALIZING ANTIBODY; PROTEIN TWEAK; STROMELYSIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; INTERVERTEBRAL DISK DEGENERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIME; UPREGULATION; WILD TYPE;

AGGRECANS; ANIMALS; ANTIBODIES, BLOCKING; ENZYME INDUCTION; GENE EXPRESSION REGULATION; GENE SILENCING; IMMUNOENZYME TECHNIQUES; INTERVERTEBRAL DISK; INTERVERTEBRAL DISK DISPLACEMENT; MATRIX METALLOPROTEINASE 3; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECOMBINANT PROTEINS; TUMOR NECROSIS FACTORS;

EID: 36749035358     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1002/jor.20445     Document Type: Article

References (28)

1. Frymoyer JW, Cats-Baril WL. 1991. An overview of the incidence and costs of low back pain. Orthop Clin North Am 22:263-271.
2. Antoniou J, Steffen T, Nelson F, et al. 1996. The human lumbar intervertebral disc: evidence for changes in the biosynthesis and denaturation of the extracellular matrix with growth, maturation, ageing, and degeneration. J Clin Invest 98:996-1003.
3. Eyre DR, Muir H. 1977. Quantitative analysis of type I and II collagens in human intervertebral discs at various ages. Biochim Biophys Acta 492:29-42.
4. Haefeli M, Kalberer F, Saegesser D, et al. 2006. The course of macroscopic degeneration in the human lumbar intervertebral disc. Spine 31:1522-1531.
5. Chicheportiche Y, Bourdon PR, Xu H, et al. 1997. TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis. J Biol Chem 272:32401-32410.
6. Lynch CN, Wang YC, Lund JK, et al. 1999. TWEAK induces angiogenesis and proliferation of endothelial cells. J Biol Chem 274:8455-8459.
7. Harada N, Nakayama M, Nakano H, et al. 2002. Proinflammatory effect of TWEAK/Fn14 interaction on human umbilical vein endothelial cells. Biochem Biophys Res Commun 299:488-493.
8. Polek TC, Talpaz M, Darnay BG, et al. 2003. TWEAK mediates signal transduction and differentiation of RAW264.7 cells in the absence of Fn/TweakR. Evidence for a second TWEAK receptor. J Biol Chem 278:32317-32323.
9. Donohue PJ, Richards CM, Brown SA, et al. 2003. TWEAK is an endothelial cell growth and chemotactic factor that also potentiates FGF-2 and VEGF-A mitogenic activity. Arterioscler Thromb Vasc Biol 23:594-600.
10. Wiley SR, Winkles JA. 2003. TWEAK, a member of the TNF superfamily, is a multifunctional cytokine that binds the TweakR/Fn14 receptor. Cytokine Growth Factor Rev 14:241-249.
11. Feng SLY, Guo Y, Factor VM, et al. 2000. The Fn14 immediate-early response gene is induced during liver regeneration and highly expressed in both human and murine hepatocellular carcinoma. Am J Pathol 156:1253-1261.
12. Campbell S, Michaelson J, Burkly L, et al. 2004. The role of TWEAK/Fn14 in the pathogenesis of inflammation and systemic autoimmunity. Front Biosci 9:2273-2284.
13. Maecker H, Varfolomeev E, Kischkel F, et al. 2005. TWEAK attenuates the transition from innate to adaptive immunity. Cell 123:931-944.
14. Chicheportiche YR, Chicheportiche I, Sizing J, et al. 2002. Proinflammatory activity of TWEAK on human dermal fibroblasts and synoviocytes: blocking and enhancing effects of anti-TWEAK monoclonal antibodies. Arthritis Res 4:126-133.
15. Haro H, Crawford HC, Fingleton B, et al. 2000. Chondrocyte Matrix Metalloproteinase-3 is required for the generation of a macrophage chemoattractant: role in macrophage infiltration in a coculture model of herniated disc resorption. J Clin Invest 105:133-141.
16. Ando T, Ichikawa J, Wako M, et al. 2006. TWEAK/Fn14 interaction regulates RANTES production, BMP-2-induced differentiation, and RANKL expression in mouse osteoblastic MC3T3-E1 cells. Arthritis Res Ther 8:R146.
17. Lipson SJ, Muir H. 1981. Experimental intervertebral disc degeneration: morphologic and proteoglycan changes over time. Arthritis Rheum 24:12-21.
18. Freemont AJ, Peacock TE, Goupille P, et al. 1997. Nerve ingrowth into diseased intervertebral disc in chronic back pain. Lancet 350:178-181.
19. Johnson WE, Evans H, Menage J, et al. 2001. Immunohistochemical detection of Schwann cells in innervated and vascularized human intervertebral discs. Spine 26:2550-2557.
20. Komori H, Shinomiya K, Nakai O, et al. 1996. The natural history of herniated nucleus pulposus with radiculopathy. Spine 21:225-229.
21. Komori H, Okawa A, Haro H, et al. 1998. Gd-DTPA contrast-enhanced magnetic resonance imaging in conservative management of lumbar disc herniation. Spine 23:67-73.
22. Haro H, Shinomiya K, Komori H, et al. 1996. Upregulated expression of chemokines in herniated nucleus pulposus resorption. Spine 21:647-652.
23. Haro H, Murakami S, Komori H, et al. 1997. Chemonucleolysis with human stromelysin-1. Spine 22:1098-1104.
24. Haro H, Crawford HC, Fingleton B, et al. 2000. Matrix metalloproteinase-7 is required for Tumor Necrosis Factor - a release from activated macrophages: role in macrophage infiltration in a coculture model of herniated disc resorption. J Clin Invest 105:143-150.
25. Haro H, Kato T, Komori H, et al. 2002. Vascular endothelial growth factor (VEGF)-induced angiogenesis in herniated disc resorption. J Orthop Res 20:409-415.
26. Kato T, Haro H, Komori H, et al. 2004. Sequential dynamics of inflammatory cytokine, angiogenesis inducing factor and matrix degrading enzymes during resorption of the spontaneous herniated disc. J Orthop Res 22:895-900.
27. Perper SJ, Browning B, Burkly LC, et al. 2006. TWEAK is a novel arthritogenic mediator. J Immunol 177:2610-2620.
28. Yoshida M, Nakamura T, Sei A, et al. 2004. Intervertebral disc cells produce tumor necrosis factor α, interleukin-1β, and monocyte chemoattractant protein-1 immediately after herniation: an experimental study using a new hernia model. Spine 30:55-61.